MGH
Charlestown, Massachusetts, 02129-2020, United States
Location status: Recruiting
NCT Number: NCT06098612
The overall goal of the proposed research is to evaluate the use of [11C]SY08 as a PET radiotracer for aggregated alpha synuclein (αS) in individuals with Parkinson's disease (PD), Multiple system atrophy (MSA), Dementia with Lewy Bodies (DLB) and healthy controls.
The purpose of this study is to evaluate the use of [11C]SY08 as a PET radiotracer for αS fibrils in individuals with PD, MSA, DLB and healthy controls. The specific aims of the current study are:
1. To determine brain uptake, distribution, and kinetics of [11C]SY08 in healthy individuals. 2. To determine brain uptake, distribution, and kinetics of [11C]SY08 in patients with alpha synuclein aggregates in the brain, including PD, DLB and MSA. 3. To determine human dosimetry of [11C]SY08 in healthy individuals
An intravenous bolus injection of [11C]SY08 will be administered per subject for brain PET imaging.
Interested in participating?
Request Info50 year–80 year
All sexes
Interventional
Early Phase 1
Charlestown, Massachusetts, 02129-2020, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Additional Inclusion criteria for PD patients, subjects must:
Additional Inclusion criteria for MSA patients, subjects must:
Additional Inclusion criteria for DLB patients, subjects must:
Exclusion criteria
General MR and PET safety exclusion criteria listed below
Exclusion criteria
for Subjects Undergoing Blood Draws Through an Arterial Line During PET Scan
a PET imaging agent
Time frame: up tp 120 minutes
The investigators will use SUV or SUV to evaluate brain uptake
Contact information is provided by the study sponsor or research team.
Massachusetts General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06445465
Alpha-Synucleinopathy, Autonomic Nervous System Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT02761707
Alzheimer Disease, Alzheimer's Disease
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07570212
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT07644013
Atypical Parkinsonism, Autonomic Nervous System Diseases
Beijing, Beijing Municipality, China
View Trial Details